Identity and heritage
Keystone
Founded by Jacques Gardette, a prominent entrepreneur from the Auvergne-Rhône-Alpes region, BIOCORP is deeply rooted in the local industrial fabric.
105 employees on 2 sites
Today, BIOCORP employs 105 people across two complementary sites. The Clermont-Ferrand site houses Development, Innovation, and Support Functions departments, while the Issoire site focuses on Production and Quality activities. This dual organization has fostered two distinct corporate cultures that have learned to collaborate effectively and strengthen each other over time.
Sovereignety over health
The COVID-19 pandemic underscored the strategic importance of linking industrial capability with healthcare sovereignty. In this context, BIOCORP has always chosen to maintain its production in France—a fundamental commitment that has proven particularly relevant.
Novo Nordisk group
In 2023, BIOCORP joined the Novo Nordisk group. This acknowledged BIOCORP’s agility and expertise in medical device development, particularly for diabetes. BIOCORP was integrated under a “stand-alone company” model, ensuring autonomous governance, a dedicated budget, and preserved agility. The company is represented within the Final Product Development & Manufacturing decision-making body of the Novo Nordisk group.
BIOCORP continues to hire talent from regional universities while its affiliation with Novo Nordisk strengthens its national visibility and appeal. At the same time, being part of the Novo Nordisk group gives it greater visibility and attractiveness, enabling it to attract profiles from all over the country.